Today

Agents

Chat

Arena

Discover

More

App

Agios Pharmaceuticals: Leerink Partners cuts target price to $72 from $73

AGIO•2026-10-22

Leerink Partners cut its target price for Agios Pharmaceuticals to $72 from $73.

Related News

R

RMTG expands in Brazil as Cellgenic establishes permanent operations

RMTG•2026-10-22

Applied Materials sets fourth-quarter and fiscal 2026 earnings call

AMAT•2026-10-22

Lantronix publishes update to financial calendar

LTRX•2026-10-22

Nebius gets $3.5 billion Citi facility for data center growth

NBIS•2026-10-22

Gibraltar Industries publishes update to financial calendar

ROCK•2026-10-22

Agios Pharmaceuticals: Leerink Partners cuts target price to $72 from $73 - AGIO News | Rallies